SCHEMBL29638579

SCHEMBL29638579

COc1ccc(F)c(Nc2nccc3cc(C)ccc23)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.44
MAPT P10636 4/20 0.42
GRM4 Q14833 1/20 0.40
TNF P01375 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
NCOA1 Q15788 1/20 0.40
NCOA3 Q9Y6Q9 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
P2RX7 Q99572 1/20 0.40
CDK4 P11802 1/20 0.39
CDK2 P24941 1/20 0.39
RET P07949 1/20 0.39
KIF5B P33176 1/20 0.39
KDR P35968 1/20 0.39
DYRK1A Q13627 1/20 0.39
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
DHODH Q02127 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29638511 0.90 DYRK1A (0.47) TRPA1MAPTNCOA1NCOA3RET
SCHEMBL29638530 0.82 HDAC3 (0.44) GRM4TNFCDK4CDK2RET
SCHEMBL29638533 0.81 NCOA1 (0.60) MAPTTNFSMN1; SMN2NCOA1NCOA3
SCHEMBL29638531 0.80 HDAC3 (0.53) GRM4RETKIF5BKDRHDAC3
SCHEMBL26210446 0.79 EGFR (0.39) SMN1; SMN2P2RX7CDK2RETKIF5B
SCHEMBL29638608 0.79 HDAC3 (0.46) MAPTSMN1; SMN2NPC1RAB9AP2RX7
Hydrochloric Acid SCHEMBL9378828 0.75 ALDH1A1 (0.44) SMN1; SMN2CDK2ALDH1A1MAPK1ADRA1D
SCHEMBL25373687 0.74 MAPT (0.40) MAPTRAB9AP2RX7KDRDHODH
SCHEMBL29638713 0.74 RAPGEF4 (0.41) TRPA1TNFHDAC3HDAC1HDAC6
SCHEMBL23624389 0.72 ABL1 (0.49) TNFNCOA1NCOA3KDRDHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022089219-A1 ARYLAMIDE COMPOUND, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD THEREFOR AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2022-05-05 WO disclosed